2023 - Research.com Immunology in Norway Leader Award
2022 - Research.com Immunology in Norway Leader Award
Pål Aukrust spends much of his time researching Internal medicine, Immunology, Endocrinology, Heart failure and Inflammation. The study incorporates disciplines such as Gastroenterology and Cardiology in addition to Internal medicine. His study in Cytokine, Tumor necrosis factor alpha, Interleukin, Chemokine and Monocyte are all subfields of Immunology.
His Endocrinology research is multidisciplinary, relying on both Receptor, Nonalcoholic fatty liver disease, T cell and Receptor antagonist. The various areas that Pål Aukrust examines in his Heart failure study include Heart disease, Rosuvastatin and Hazard ratio. His study in Inflammation is interdisciplinary in nature, drawing from both Lesion, Pathogenesis, Platelet activation, Platelet and Vascular disease.
Pål Aukrust mainly investigates Internal medicine, Immunology, Inflammation, Endocrinology and Cardiology. His research links Gastroenterology with Internal medicine. Much of his study explores Immunology relationship to Peripheral blood mononuclear cell.
His studies in Inflammation integrate themes in fields like Platelet activation, Receptor and Pathogenesis, Pathology. His Endocrinology research is multidisciplinary, incorporating perspectives in Inflammasome and Osteoprotegerin. His Cardiology study combines topics from a wide range of disciplines, such as Surgery and Hazard ratio.
Pål Aukrust mostly deals with Internal medicine, Inflammation, Immunology, Endocrinology and Cardiology. His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology. His Inflammation study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Lipoprotein, Transplantation and Monocyte.
His studies deal with areas such as Peripheral blood mononuclear cell and Disease as well as Immunology. Insulin resistance is closely connected to Inflammasome in his research, which is encompassed under the umbrella topic of Endocrinology. As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Randomized controlled trial, and often Rosuvastatin.
Internal medicine, Immunology, Inflammation, Myocardial infarction and Cardiology are his primary areas of study. Pål Aukrust interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine. As a part of the same scientific study, he usually deals with the Immunology, concentrating on Odds ratio and frequently concerns with Respiratory system, Case-control study, Complement system, Lectin pathway and Coronavirus.
The Inflammation study combines topics in areas such as COPD, Lung cancer, FOXP3 and Innate immune system. His biological study spans a wide range of topics, including Coronary artery disease and Tocilizumab, Disease. The concepts of his Cardiology study are interwoven with issues in Endurance training, Physical exercise and C-reactive protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo.
The New England Journal of Medicine (2020)
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes
Pål Aukrust;Fredrik Müller;Thor Ueland;Trude Berget.
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen.
American Journal of Cardiology (1999)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland;Jan Kristian Damås;Zbigniew Konopski;Else Marit Løberg.
Journal of Hepatology (2006)
Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure
Pål Aukrust;Thor Ueland;Fredrik Müller;Arne K. Andreassen.
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
Lars Gullestad;Halfdan Aass;Jan G. Fjeld;Lisbeth Wikeby.
Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters.
P Aukrust;N B Liabakk;F Müller;E Lien.
The Journal of Infectious Diseases (1994)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
Øystein Sandanger;Trine Ranheim;Leif Erik Vinge;Leif Erik Vinge;Marte Bliksøen.
Cardiovascular Research (2013)
Systemic inflammation in heart failure--the whys and wherefores.
Arne Yndestad;Jan Kristian Damås;Erik Oie;Thor Ueland.
Heart Failure Reviews (2006)
Inflammatory cytokines in heart failure: mediators and markers.
Lars Gullestad;Thor Ueland;Leif Erik Vinge;Alexandra Finsen.
The Cardiology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: